Skip to content

Drug interactions

Flecainide + Gilteritinib

Severity: Major

Flecainide and Gilteritinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Gilteritinib can cause QT prolongation, and flecainide slows cardiac conduction. The combination may increase the risk of ventricular arrhythmia.

What this interaction means in plain words

Flecainide and Gilteritinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Flecainide belongs to Cardiovascular; Gilteritinib belongs to Oncology.

Evidence level: Low

Why it happens

Additive pharmacodynamic effects on cardiac conduction and repolarization.

What to do

Avoid the combination if possible. If it cannot be avoided, obtain ECGs at baseline and during treatment, and correct potassium and magnesium abnormalities.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Flecainide and Gilteritinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Flecainide with Gilteritinib?

MediHelp rates the interaction as major. Flecainide and Gilteritinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Gilteritinib can cause QT prolongation, and flecainide slows cardiac conduction. The combination may increase the risk of ventricular arrhythmia.

How serious is the interaction between Flecainide and Gilteritinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible. If it cannot be avoided, obtain ECGs at baseline and during treatment, and correct potassium and magnesium abnormalities.

What other medicines interact with Flecainide?

MediHelp also lists interactions of Flecainide with, for example, Nirmatrelvir, Nirmatrelvir / ritonavir, Pimozide. The full list is on the Flecainide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in